Monosymptomatic hyperthyroidism and TSH-producing adenoma: Successful treatment with octreotide;Monosymptomatische hyperthyreose und TSH-produzierendes adenom: Erfolgreiche therapie mit octreotid

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 4, 1999, Pages 73-78

  Mayinger, Brigitte ^a,b   Axelos, David ^a,b   Pavel, Marianne ^a,b   Hahn, Eckart Georg ^a,b   Hensen, J ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADENOMA; AGED; ARTICLE; BRAIN TUMOR; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HYPERTHYROIDISM; NUCLEAR MAGNETIC RESONANCE IMAGING; THYROID SCINTISCANNING;

EID: 0033613663     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024245     Document Type: Article

References (20)

1. 111In-Octreotide szintigraphy. Nucl. med. 34 81995), 100-103.
2. 2 Beck-Peccoz, P., L. Persani, G. Faglia: Glycoprotein hormone alpha-subunit in pituitary adenomas. Trends Endocrinol. Metabol. 3 (1992), 41-46.
3. 3 Beck-Peccoz, P., F. Brucker-Davis, L. Persani, R. C. Smallridge, B. D. Weintraub: Thyrotropin-secreting pituitary tumors. Endocr. Rev. 17 (1996), 610-638.
4. 4 Beck-Peccoz, P., L. Persani, C. Asteria, R. Romoli. In von Werder K., Fahlbusch, R. (Eds): TSH-secreting pituitary adenomas in pituitary adenomas from basic research to diagnosis and therapy. (Elsevier, Amsterdam 1996), 277-300.
5. 5 Benoit, R., B. E. Pearson-Murphy, F. Robert, S. Marcovitz, J. Hardy, G. Tsoukas, R. J. Gardiner: Hyperthyroidism due to a pituitary TSH secreting tumor with amenorrhoe-galactorrhoea. Clin. Endocrinol. 12 (1980), 11-19.
6. 6 Chanson, P., A. Warnet: Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide. Metabolism 41 (1992), 62-65.
7. 7 Chanson, P., B. D. Weintraub, A. G. Harris: Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann. intern. Med. 119 (1993), 236-40.
8. 8 Chatterjee, V. K.: Resistance to thyroid hormone. Horm. Res. 48 (1997), 43-46.
9. 9 Chayen, S., D. Gross, O. Makhoul, B. Glaser: TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide. Horm. metabol. Res. 24 (1992), 34-38.
10. 10 Duello, T. M., N. S. Halmi: Pituitary adenoma producing thyrotropin and prolactin. Virchows Arch. Pathol. Anat. 37 (1977), 255-265.
11. 11 Franklyn, J. A.: Thyroid hormone resistance syndromes are generalized and selective pituitary resistance part of the same disorder? Clin. Endocrinol. 38 (1993), 235-236.
12. 12 Gesundheit, N., P. Petrick, M. Nissim, P. A. Dahlberg, J. L. Doppman, C. E. Emerson, L. E. Bravermann, E. H. Oldfield, B. D. Weintraub: Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann. intern. Med. 11 (1989), 827-835.
13. 13 Horn, K., F. Erhardt, R. Fahlbusch, C. R. Pickardt, K. v. Werder, P. C. Scriba. Recurrent goiter, hyperthyroidism, galactorrhea and amennorrhea due to a thyrotropin and prolactin-producing pituitary tumor. J. clin. Endocrinol 43 (1976), 137-143.
14. 14 Lamberg, B. A., R. Pelkonen, A. Gordin, M. Haltia, T. Wahlström, A. Paetau, J. Leppaluoto: Hyperthyroidism and acromegaly caused by a pituitary TSH-and GH-secreting tumor. Acta endocrinol. 103 (1983), 7-14.
15. 15 McCutcheon, I. E., B. D. Weintraub, E. H. Oldfield: Surgical treatment of thyrotropin secreting pituitary adenomas. J. Neurosurg. 73 (1990), 674-683.
16. 16 Mindermann, T., C. B. Wilson: Thyrotropin-producing pituitary adenomas. J. Neurosurg. 73 (1993), 521-527.
17. 17 Refetoff, S., R. E. Weiss, S. J. Usala: The syndromes of resistance to thyroid hormone. Endocr. Rev. 14 (1993), 348-399.
18. 18 Reschke, K., T. Rohrer, D. Kopf, S. Klose, O. Hey, A. Perneczky, H. Lehnert: Hyperthyreose bei TSH-produzierendem Hypophysenadenom. Dtsch. med. Wschr. 122 (1997), 150-155.
19. 19 Schmidt, K., P. H. Althoff, A. G. Harris, H. Prestele, P. M. Schumm-Draeger, K. H. Usadel. Analgetic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind study with long-term follow up. Pain 53 (1993), 223-227.
20. 20 Warnet, A., E. Lajeunie, F. Gelbert, M. Duet, P. Chanson, J. Cophignon, A. G. Harris: Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995). Acta endocrinol (Copenh) 124 (1991), 487-491.